메뉴 건너뛰기




Volumn 126, Issue 3, 2016, Pages 799-808

Beyond antigens and adjuvants: Formulating future vaccines

Author keywords

[No Author keywords available]

Indexed keywords

NANOPARTICLE; SUBUNIT VACCINE; VACCINE; ANTIGEN; IMMUNOLOGICAL ADJUVANT;

EID: 84959873965     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI81083     Document Type: Review
Times cited : (300)

References (133)
  • 1
    • 84878356025 scopus 로고    scopus 로고
    • Accelerating next-generation vaccine development for global disease prevention
    • Koff WC, et al. Accelerating next-generation vaccine development for global disease prevention. Science. 2013;340(6136):1232910.
    • (2013) Science , vol.340 , Issue.6136 , pp. 1232910
    • Koff, W.C.1
  • 2
    • 44049108744 scopus 로고    scopus 로고
    • Toward an AIDS vaccine
    • Walker BD, Burton DR. Toward an AIDS vaccine. Science. 2008;320(5877):760-764.
    • (2008) Science , vol.320 , Issue.5877 , pp. 760-764
    • Walker, B.D.1    Burton, D.R.2
  • 3
    • 84873506978 scopus 로고    scopus 로고
    • Designing tomorrow's vaccines
    • Nabel GJ. Designing tomorrow's vaccines. N Engl J Med. 2013;368(6):551-560.
    • (2013) N Engl J Med , vol.368 , Issue.6 , pp. 551-560
    • Nabel, G.J.1
  • 5
    • 84889770121 scopus 로고    scopus 로고
    • Key roles of adjuvants in modern vaccines
    • Reed SG, Orr MT, Fox CB. Key roles of adjuvants in modern vaccines. Nat Med. 2013;19(12):1597-1608.
    • (2013) Nat Med , vol.19 , Issue.12 , pp. 1597-1608
    • Reed, S.G.1    Orr, M.T.2    Fox, C.B.3
  • 6
    • 30544448127 scopus 로고    scopus 로고
    • Triggering TLR signaling in vaccination
    • van Duin D, Medzhitov R, Shaw AC. Triggering TLR signaling in vaccination. Trends Immunol. 2006;27(1):49-55.
    • (2006) Trends Immunol , vol.27 , Issue.1 , pp. 49-55
    • Van Duin, D.1    Medzhitov, R.2    Shaw, A.C.3
  • 7
    • 0035830278 scopus 로고    scopus 로고
    • Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in the Gambia: A randomised trial
    • Bojang KA, et al. Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet. 2001;358(9297):1927-1934.
    • (2001) Lancet , vol.358 , Issue.9297 , pp. 1927-1934
    • Bojang, K.A.1
  • 8
    • 84914695671 scopus 로고    scopus 로고
    • Antibody persistence and T-cell balance: Two key factors confronting HIV vaccine development
    • Lewis GK, DeVico AL, Gallo RC. Antibody persistence and T-cell balance: two key factors confronting HIV vaccine development. Proc Natl Acad Sci U S A. 2014;111(44):15614-15621.
    • (2014) Proc Natl Acad Sci U S A , vol.111 , Issue.44 , pp. 15614-15621
    • Lewis, G.K.1    DeVico, A.L.2    Gallo, R.C.3
  • 9
    • 84863774072 scopus 로고    scopus 로고
    • Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses
    • Burton DR, Poignard P, Stanfield RL, Wilson IA. Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses. Science. 2012;337(6091):183-186.
    • (2012) Science , vol.337 , Issue.6091 , pp. 183-186
    • Burton, D.R.1    Poignard, P.2    Stanfield, R.L.3    Wilson, I.A.4
  • 10
    • 84861963478 scopus 로고    scopus 로고
    • The mechanism of action of MF59-an innately attractive adjuvant formulation
    • O'Hagan DT, Ott GS, De Gregorio E, Seubert A. The mechanism of action of MF59-an innately attractive adjuvant formulation. Vaccine. 2012;30(29):4341-4348.
    • (2012) Vaccine , vol.30 , Issue.29 , pp. 4341-4348
    • O'Hagan, D.T.1    Ott, G.S.2    De Gregorio, E.3    Seubert, A.4
  • 11
    • 0032827427 scopus 로고    scopus 로고
    • Distribution of adjuvant MF59 and antigen gD2 after intramuscular injection in mice
    • Dupuis M, McDonald DM, Ott G. Distribution of adjuvant MF59 and antigen gD2 after intramuscular injection in mice. Vaccine. 1999; 18(5-6):434-439.
    • (1999) Vaccine , vol.18 , Issue.5-6 , pp. 434-439
    • Dupuis, M.1    McDonald, D.M.2    Ott, G.3
  • 12
    • 77956405814 scopus 로고    scopus 로고
    • The kinetics of soluble and particulate antigen trafficking in the afferent lymph, and its modulation by aluminum-based adjuvant
    • De Veer M, Kemp J, Chatelier J, Elhay MJ, Meeusen EN. The kinetics of soluble and particulate antigen trafficking in the afferent lymph, and its modulation by aluminum-based adjuvant. Vaccine. 2010;28(40):6597-6602.
    • (2010) Vaccine , vol.28 , Issue.40 , pp. 6597-6602
    • De Veer, M.1    Kemp, J.2    Chatelier, J.3    Elhay, M.J.4    Meeusen, E.N.5
  • 13
    • 84922573075 scopus 로고    scopus 로고
    • Vaccine adjuvant MF59 promotes retention of unprocessed antigen in lymph node macrophage compartments and follicular dendritic cells
    • Cantisani R, et al. Vaccine adjuvant MF59 promotes retention of unprocessed antigen in lymph node macrophage compartments and follicular dendritic cells. J Immunol. 2015;194(4):1717-1725.
    • (2015) J Immunol , vol.194 , Issue.4 , pp. 1717-1725
    • Cantisani, R.1
  • 14
    • 0025287316 scopus 로고
    • Effect of molecular weight on the lymphatic absorption of water-soluble compounds following subcutaneous administration
    • Supersaxo A, Hein WR, Steffen H. Effect of molecular weight on the lymphatic absorption of water-soluble compounds following subcutaneous administration. Pharm Res. 1990;7(2):167-169.
    • (1990) Pharm Res , vol.7 , Issue.2 , pp. 167-169
    • Supersaxo, A.1    Hein, W.R.2    Steffen, H.3
  • 15
    • 80053228071 scopus 로고    scopus 로고
    • Secretion of adipokines by human adipose tissue in vivo: Partitioning between capillary and lymphatic transport
    • Miller NE, et al. Secretion of adipokines by human adipose tissue in vivo: partitioning between capillary and lymphatic transport. Am J Physiol Endocrinol Metab. 2011;301(4):E659-E667.
    • (2011) Am J Physiol Endocrinol Metab , vol.301 , Issue.4 , pp. E659-E667
    • Miller, N.E.1
  • 16
    • 79960373302 scopus 로고    scopus 로고
    • Vaccine adjuvant activity of 3M-052: An imidazoquinoline designed for local activity without systemic cytokine induction
    • Smirnov D, Schmidt JJ, Capecchi JT, Wightman PD. Vaccine adjuvant activity of 3M-052: an imidazoquinoline designed for local activity without systemic cytokine induction. Vaccine. 2011;29(33):5434-5442.
    • (2011) Vaccine , vol.29 , Issue.33 , pp. 5434-5442
    • Smirnov, D.1    Schmidt, J.J.2    Capecchi, J.T.3    Wightman, P.D.4
  • 17
    • 84876561994 scopus 로고    scopus 로고
    • Peripherally administered nanoparticles target monocytic myeloid cells, secondary lymphoid organs and tumors in mice
    • Kourtis IC, et al. Peripherally administered nanoparticles target monocytic myeloid cells, secondary lymphoid organs and tumors in mice. PLoS One. 2013;8(4):e61646.
    • (2013) PLoS One , vol.8 , Issue.4 , pp. e61646
    • Kourtis, I.C.1
  • 18
    • 70849093813 scopus 로고    scopus 로고
    • Materials engineering for immunomodulation
    • Hubbell JA, Thomas SN, Swartz MA. Materials engineering for immunomodulation. Nature. 2009;462(7272):449-460.
    • (2009) Nature , vol.462 , Issue.7272 , pp. 449-460
    • Hubbell, J.A.1    Thomas, S.N.2    Swartz, M.A.3
  • 19
    • 78049288264 scopus 로고    scopus 로고
    • Vaccine delivery: A matter of size, geometry, kinetics and molecular patterns
    • Bachmann MF, Jennings GT. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol. 2010;10(11):787-796.
    • (2010) Nat Rev Immunol , vol.10 , Issue.11 , pp. 787-796
    • Bachmann, M.F.1    Jennings, G.T.2
  • 20
    • 4344697146 scopus 로고    scopus 로고
    • Size-dependent immunogenicity: Therapeutic and protective properties of nano-vaccines against tumors
    • Fifis T, et al. Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors. J Immunol. 2004;173(5):3148.
    • (2004) J Immunol , vol.173 , Issue.5 , pp. 3148
    • Fifis, T.1
  • 21
    • 35148889797 scopus 로고    scopus 로고
    • Exploiting lymphatic transport and complement activation in nanoparticle vaccines
    • Reddy ST, et al. Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat Biotechnol. 2007;25(10):1159-1164.
    • (2007) Nat Biotechnol , vol.25 , Issue.10 , pp. 1159-1164
    • Reddy, S.T.1
  • 22
    • 33646480406 scopus 로고    scopus 로고
    • In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles
    • Reddy ST, Rehor A, Schmoekel HG, Hubbell JA, Swartz MA. In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles. J Control Release. 2006;112(1):26-34.
    • (2006) J Control Release , vol.112 , Issue.1 , pp. 26-34
    • Reddy, S.T.1    Rehor, A.2    Schmoekel, H.G.3    Hubbell, J.A.4    Swartz, M.A.5
  • 23
    • 47049100427 scopus 로고    scopus 로고
    • Nanoparticles target distinct dendritic cell populations accorDing to their size
    • Manolova V, Flace A, Bauer M, Schwarz K, Saudan P, Bachmann MF. Nanoparticles target distinct dendritic cell populations accorDing to their size. Eur J Immunol. 2008;38(5):1404-1413.
    • (2008) Eur J Immunol , vol.38 , Issue.5 , pp. 1404-1413
    • Manolova, V.1    Flace, A.2    Bauer, M.3    Schwarz, K.4    Saudan, P.5    Bachmann, M.F.6
  • 24
    • 33644529130 scopus 로고    scopus 로고
    • Capturing complex 3D tissue physiology in vitro
    • Griffith LG, Swartz MA. Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol. 2006;7(3):211-224.
    • (2006) Nat Rev Mol Cell Biol , vol.7 , Issue.3 , pp. 211-224
    • Griffith, L.G.1    Swartz, M.A.2
  • 25
    • 0030982397 scopus 로고    scopus 로고
    • Lymphatic uptake and biodistribution of liposomes after subcutaneous injection
    • Oussoren C, Zuidema J, Crommelin D, Storm G. Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. Biochim Biophys Acta. 1997;1328(2):261-272.
    • (1997) Biochim Biophys Acta , vol.1328 , Issue.2 , pp. 261-272
    • Oussoren, C.1    Zuidema, J.2    Crommelin, D.3    Storm, G.4
  • 26
    • 84879882264 scopus 로고    scopus 로고
    • Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
    • Kanekiyo M, et al. Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. Nature. 2013;499(7456):102-106.
    • (2013) Nature , vol.499 , Issue.7456 , pp. 102-106
    • Kanekiyo, M.1
  • 27
    • 84860335491 scopus 로고    scopus 로고
    • Innate immunity mediates follicular transport of particulate but not soluble protein antigen
    • Link A, Zabel F, Schnetzler Y, Titz A, Brombacher F, Bachmann MF. Innate immunity mediates follicular transport of particulate but not soluble protein antigen. J Immunol. 2012;188(8):3724-3733.
    • (2012) J Immunol , vol.188 , Issue.8 , pp. 3724-3733
    • Link, A.1    Zabel, F.2    Schnetzler, Y.3    Titz, A.4    Brombacher, F.5    Bachmann, M.F.6
  • 28
    • 0034898470 scopus 로고    scopus 로고
    • Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies
    • Chackerian B, Lowy DR, Schiller JT. Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies. J Clin Invest. 2001;108(3):415.
    • (2001) J Clin Invest , vol.108 , Issue.3 , pp. 415
    • Chackerian, B.1    Lowy, D.R.2    Schiller, J.T.3
  • 29
    • 79951899834 scopus 로고    scopus 로고
    • Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses
    • Moon JJ, et al. Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses. Nat Mater. 2011;10(3):243-251.
    • (2011) Nat Mater , vol.10 , Issue.3 , pp. 243-251
    • Moon, J.J.1
  • 30
    • 81055130325 scopus 로고    scopus 로고
    • Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination
    • Nembrini C, et al. Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination. Proc Natl Acad Sci U S A. 2011;108(44):E989-E997.
    • (2011) Proc Natl Acad Sci U S A , vol.108 , Issue.44 , pp. E989-E997
    • Nembrini, C.1
  • 31
    • 84884676871 scopus 로고    scopus 로고
    • Generation of effector memory T cell-based mucosal and systemic immunity with pulmonary nanoparticle vaccination
    • Li AV, et al. Generation of effector memory T cell-based mucosal and systemic immunity with pulmonary nanoparticle vaccination. Sci Transl Med. 2013;5(204):204ra130.
    • (2013) Sci Transl Med , vol.5 , Issue.204 , pp. 204ra130
    • Li, A.V.1
  • 32
    • 78049361384 scopus 로고    scopus 로고
    • TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis
    • Demento SL, et al. TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis. J Immunol. 2010;185(5):2989-2997.
    • (2010) J Immunol , vol.185 , Issue.5 , pp. 2989-2997
    • Demento, S.L.1
  • 33
    • 77953961068 scopus 로고    scopus 로고
    • Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response
    • Henriksen-Lacey M, et al. Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response. J Control Release. 2010;145(2):102-108.
    • (2010) J Control Release , vol.145 , Issue.2 , pp. 102-108
    • Henriksen-Lacey, M.1
  • 34
    • 84915751154 scopus 로고    scopus 로고
    • A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human
    • van Dissel JT, et al. A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human. Vaccine. 2014;32(52):7098-7107.
    • (2014) Vaccine , vol.32 , Issue.52 , pp. 7098-7107
    • Van Dissel, J.T.1
  • 35
    • 84856387516 scopus 로고    scopus 로고
    • Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction
    • Moon JJ, Suh H, Li AV, Ockenhouse CF, Yadava A, Irvine DJ. Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction. Proc Natl Acad Sci U S A. 2012;109(4):1080-1085.
    • (2012) Proc Natl Acad Sci U S A , vol.109 , Issue.4 , pp. 1080-1085
    • Moon, J.J.1    Suh, H.2    Li, A.V.3    Ockenhouse, C.F.4    Yadava, A.5    Irvine, D.J.6
  • 36
    • 84897954314 scopus 로고    scopus 로고
    • Structure-based programming of lymph-node targeting in molecular vaccines
    • Liu H, et al. Structure-based programming of lymph-node targeting in molecular vaccines. Nature. 2014;507(7493):519-522.
    • (2014) Nature , vol.507 , Issue.7493 , pp. 519-522
    • Liu, H.1
  • 37
    • 84900461408 scopus 로고    scopus 로고
    • Development and function of dendritic cell subsets
    • Mildner A, Jung S. Development and function of dendritic cell subsets. Immunity. 2014;40(5):642-656.
    • (2014) Immunity , vol.40 , Issue.5 , pp. 642-656
    • Mildner, A.1    Jung, S.2
  • 38
    • 33846636409 scopus 로고    scopus 로고
    • Differential antigen processing by dendritic cell subsets in vivo
    • Dudziak D, et al. Differential antigen processing by dendritic cell subsets in vivo. Science. 2007;315(5808):107-111.
    • (2007) Science , vol.315 , Issue.5808 , pp. 107-111
    • Dudziak, D.1
  • 39
    • 84255186425 scopus 로고    scopus 로고
    • Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity
    • Tacken PJ, et al. Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity. Blood. 2011;118(26):6836-6844.
    • (2011) Blood , vol.118 , Issue.26 , pp. 6836-6844
    • Tacken, P.J.1
  • 40
    • 40449116336 scopus 로고    scopus 로고
    • Engineered lentivector targeting of dendritic cells for in vivo immunization
    • Yang L, et al. Engineered lentivector targeting of dendritic cells for in vivo immunization. Nat Biotechnol. 2008;26(3):326-334.
    • (2008) Nat Biotechnol , vol.26 , Issue.3 , pp. 326-334
    • Yang, L.1
  • 41
    • 84899073975 scopus 로고    scopus 로고
    • Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205
    • Dhodapkar MV, et al. Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205. Sci Transl Med. 2014;6(232):232ra251.
    • (2014) Sci Transl Med , vol.6 , Issue.232 , pp. 232ra251
    • Dhodapkar, M.V.1
  • 42
    • 84856557403 scopus 로고    scopus 로고
    • Boosting antibody responses by targeting antigens to dendritic cells
    • Caminschi I, Shortman K. Boosting antibody responses by targeting antigens to dendritic cells. Trends Immunol. 2012;33(2):71-77.
    • (2012) Trends Immunol , vol.33 , Issue.2 , pp. 71-77
    • Caminschi, I.1    Shortman, K.2
  • 43
    • 34748886192 scopus 로고    scopus 로고
    • Dendritic-cell immunotherapy: From ex vivo loaDing to in vivo targeting
    • Tacken PJ, de Vries IJM, Torensma R, Figdor CG. Dendritic-cell immunotherapy: from ex vivo loaDing to in vivo targeting. Nat Rev Immunol. 2007;7(10):790-802.
    • (2007) Nat Rev Immunol , vol.7 , Issue.10 , pp. 790-802
    • Tacken, P.J.1    De Vries, I.J.M.2    Torensma, R.3    Figdor, C.G.4
  • 44
    • 35349028297 scopus 로고    scopus 로고
    • Glaxo-SmithKline Adjuvant Systems in vaccines: Concepts, achievements and perspectives
    • Garçon N, Chomez P, Van Mechelen M. Glaxo-SmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives. Expert Rev Vaccines. 2007;6(5):723-739.
    • (2007) Expert Rev Vaccines , vol.6 , Issue.5 , pp. 723-739
    • Garçon, N.1    Chomez, P.2    Van Mechelen, M.3
  • 45
    • 57649115306 scopus 로고    scopus 로고
    • Efficacy of RTS, S/AS01E vaccine against malaria in children 5 to 17 months of age
    • Bejon P, et al. Efficacy of RTS, S/AS01E vaccine against malaria in children 5 to 17 months of age. N Engl J Med. 2008;359(24):2521-2532.
    • (2008) N Engl J Med , vol.359 , Issue.24 , pp. 2521-2532
    • Bejon, P.1
  • 46
    • 78751704428 scopus 로고    scopus 로고
    • Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: A randomised controlled trial
    • Olotu A, et al. Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial. Lancet Infect Dis. 2011;11(2):102-109.
    • (2011) Lancet Infect Dis , vol.11 , Issue.2 , pp. 102-109
    • Olotu, A.1
  • 47
    • 84899912149 scopus 로고    scopus 로고
    • Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release
    • Ilyinskii PO, et al. Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release. Vaccine. 2014;32(24):2882-2895.
    • (2014) Vaccine , vol.32 , Issue.24 , pp. 2882-2895
    • Ilyinskii, P.O.1
  • 48
    • 79952173864 scopus 로고    scopus 로고
    • Programming the magnitude and persistence of antibody responses with innate immunity
    • Kasturi SP, et al. Programming the magnitude and persistence of antibody responses with innate immunity. Nature. 2011;470(7335):543-547.
    • (2011) Nature , vol.470 , Issue.7335 , pp. 543-547
    • Kasturi, S.P.1
  • 49
    • 84930388443 scopus 로고    scopus 로고
    • Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants
    • Hanson MC, et al. Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants. J Clin Invest. 2015;125(6):2352-2546.
    • (2015) J Clin Invest , vol.125 , Issue.6 , pp. 2352-2546
    • Hanson, M.C.1
  • 50
    • 84911911677 scopus 로고    scopus 로고
    • Rational design of small molecules as vaccine adjuvants
    • Wu TY-H, et al. Rational design of small molecules as vaccine adjuvants. Sci Transl Med. 2014;6(263):263ra160.
    • (2014) Sci Transl Med , vol.6 , Issue.263 , pp. 263ra160
    • Wu, T.Y.-H.1
  • 51
    • 77953541634 scopus 로고    scopus 로고
    • Inflammatory cytokines as a third signal for T cell activation
    • Curtsinger JM, Mescher MF. Inflammatory cytokines as a third signal for T cell activation. Curr Opin Immunol. 2010;22(3):333-340.
    • (2010) Curr Opin Immunol , vol.22 , Issue.3 , pp. 333-340
    • Curtsinger, J.M.1    Mescher, M.F.2
  • 52
    • 79956079190 scopus 로고    scopus 로고
    • Immunological mechanisms of vaccination
    • Pulendran B, Ahmed R. Immunological mechanisms of vaccination. Nat Immunol. 2011;12(6):509-517.
    • (2011) Nat Immunol , vol.12 , Issue.6 , pp. 509-517
    • Pulendran, B.1    Ahmed, R.2
  • 53
    • 84907302142 scopus 로고    scopus 로고
    • Dendritic cell subsets require cis-activation for cytotoxic CD8 T-cell induction
    • Desch AN, et al. Dendritic cell subsets require cis-activation for cytotoxic CD8 T-cell induction. Nat Commun. 2014;5:4674.
    • (2014) Nat Commun , vol.5 , pp. 4674
    • Desch, A.N.1
  • 54
    • 13944260898 scopus 로고    scopus 로고
    • Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function
    • Sporri R, Reis e Sousa C. Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function. Nat Immunol. 2005;6(2):163-170.
    • (2005) Nat Immunol , vol.6 , Issue.2 , pp. 163-170
    • Sporri, R.1    Reis Sousa, E.C.2
  • 55
    • 27844541797 scopus 로고    scopus 로고
    • Control of B-cell responses by Toll-like receptors
    • Pasare C, Medzhitov R. Control of B-cell responses by Toll-like receptors. Nature. 2005;438(7066):364-368.
    • (2005) Nature , vol.438 , Issue.7066 , pp. 364-368
    • Pasare, C.1    Medzhitov, R.2
  • 56
    • 33645734929 scopus 로고    scopus 로고
    • Toll-dependent selection of microbial antigens for presentation by dendritic cells
    • Blander JM, Medzhitov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature. 2006;440(7085):808-812.
    • (2006) Nature , vol.440 , Issue.7085 , pp. 808-812
    • Blander, J.M.1    Medzhitov, R.2
  • 57
    • 70350569886 scopus 로고    scopus 로고
    • Liposome-encapsulated HIV-1 Gag p24 containing lipid A induces effector CD4+ T-cells, memory CD8+ T-cells, and pro-inflammatory cytokines
    • Steers NJ, Peachman KK, McClain S, Alving CR, Rao M. Liposome-encapsulated HIV-1 Gag p24 containing lipid A induces effector CD4+ T-cells, memory CD8+ T-cells, and pro-inflammatory cytokines. Vaccine. 2009;27(49):6939-6949.
    • (2009) Vaccine , vol.27 , Issue.49 , pp. 6939-6949
    • Steers, N.J.1    Peachman, K.K.2    McClain, S.3    Alving, C.R.4    Rao, M.5
  • 58
    • 78650546875 scopus 로고    scopus 로고
    • PPS nanoparticles as versatile delivery system to induce systemic and broad mucosal immunity after intranasal administration
    • Stano A, van der Vlies AJ, Martino MM, Swartz MA, Hubbell JA, Simeoni E. PPS nanoparticles as versatile delivery system to induce systemic and broad mucosal immunity after intranasal administration. Vaccine. 2011;29(4):804-812.
    • (2011) Vaccine , vol.29 , Issue.4 , pp. 804-812
    • Stano, A.1    Van Der Vlies, A.J.2    Martino, M.M.3    Swartz, M.A.4    Hubbell, J.A.5    Simeoni, E.6
  • 59
    • 79952745936 scopus 로고    scopus 로고
    • Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response
    • Hou B, et al. Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response. Immunity. 2011;34(3):375-384.
    • (2011) Immunity , vol.34 , Issue.3 , pp. 375-384
    • Hou, B.1
  • 60
    • 84868094428 scopus 로고    scopus 로고
    • Nano-particle vaccination combined with TLR-7 and-9 ligands triggers memory and effector CD8(+) T-cell responses in melanoma patients
    • Goldinger SM, et al. Nano-particle vaccination combined with TLR-7 and-9 ligands triggers memory and effector CD8(+) T-cell responses in melanoma patients. Eur J Immunol. 2012;42(11):3049-3061.
    • (2012) Eur J Immunol , vol.42 , Issue.11 , pp. 3049-3061
    • Goldinger, S.M.1
  • 61
    • 34247891509 scopus 로고    scopus 로고
    • Immunologically active autoantigens: The role of toll-like receptors in the development of chronic inflammatory disease
    • Marshak-Rothstein A, Rifkin IR. Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease. Annu Rev Immunol. 2007;25:419-441.
    • (2007) Annu Rev Immunol , vol.25 , pp. 419-441
    • Marshak-Rothstein, A.1    Rifkin, I.R.2
  • 62
    • 84920935888 scopus 로고    scopus 로고
    • Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance
    • Maldonado RA, et al. Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance. Proc Natl Acad Sci U S A. 2015;112(2):E156-E165.
    • (2015) Proc Natl Acad Sci U S A , vol.112 , Issue.2 , pp. E156-E165
    • Maldonado, R.A.1
  • 63
    • 42949160629 scopus 로고    scopus 로고
    • The potency of the adjuvant, CpG oligos, is enhanced by encapsulation in PLG microparticles
    • Malyala P, et al. The potency of the adjuvant, CpG oligos, is enhanced by encapsulation in PLG microparticles. J Pharm Sci. 2008;97(3):1155-1164.
    • (2008) J Pharm Sci , vol.97 , Issue.3 , pp. 1155-1164
    • Malyala, P.1
  • 64
    • 80053161466 scopus 로고    scopus 로고
    • In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles
    • Jewell CM, Lopez SC, Irvine DJ. In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles. Proc Natl Acad Sci U S A. 2011;108(38):15745-15750.
    • (2011) Proc Natl Acad Sci U S A , vol.108 , Issue.38 , pp. 15745-15750
    • Jewell, C.M.1    Lopez, S.C.2    Irvine, D.J.3
  • 65
    • 27244443079 scopus 로고    scopus 로고
    • HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates
    • Wille-Reece U, et al. HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates. Proc Natl Acad Sci U S A. 2005;102(42):15190-15194.
    • (2005) Proc Natl Acad Sci U S A , vol.102 , Issue.42 , pp. 15190-15194
    • Wille-Reece, U.1
  • 66
    • 79955505656 scopus 로고    scopus 로고
    • Protective T cell immunity in mice following protein-TLR7/8 agonist-conjugate immunization requires aggregation, type i IFN, and multiple DC subsets
    • Kastenmüller K, et al. Protective T cell immunity in mice following protein-TLR7/8 agonist-conjugate immunization requires aggregation, type I IFN, and multiple DC subsets. J Clin Invest. 2011;121(5):1782.
    • (2011) J Clin Invest , vol.121 , Issue.5 , pp. 1782
    • Kastenmüller, K.1
  • 67
    • 80052941503 scopus 로고    scopus 로고
    • TLR7 enables cross-presentation by multiple dendritic cell subsets through a type i IFN-dependent pathway
    • Oh JZ, Kurche JS, Burchill MA, Kedl RM. TLR7 enables cross-presentation by multiple dendritic cell subsets through a type I IFN-dependent pathway. Blood. 2011;118(11):3028-3038.
    • (2011) Blood , vol.118 , Issue.11 , pp. 3028-3038
    • Oh, J.Z.1    Kurche, J.S.2    Burchill, M.A.3    Kedl, R.M.4
  • 68
    • 84946572121 scopus 로고    scopus 로고
    • In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity
    • Lynn GM, et al. In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity. Nat Biotechnol. 2015;33(11):1201-1210.
    • (2015) Nat Biotechnol , vol.33 , Issue.11 , pp. 1201-1210
    • Lynn, G.M.1
  • 69
    • 84889650175 scopus 로고    scopus 로고
    • Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose
    • de Titta A, et al. Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose. Proc Natl Acad Sci U S A. 2013;110(49):19902-19907.
    • (2013) Proc Natl Acad Sci U S A , vol.110 , Issue.49 , pp. 19902-19907
    • De Titta, A.1
  • 70
    • 79951899834 scopus 로고    scopus 로고
    • Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses
    • Moon JJ, et al. Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses. Nat Mater. 2011;10(3):243-251.
    • (2011) Nat Mater , vol.10 , Issue.3 , pp. 243-251
    • Moon, J.J.1
  • 71
    • 23944489407 scopus 로고    scopus 로고
    • Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells
    • Napolitani G, Rinaldi A, Bertoni F, Sallusto F, Lanzavecchia A. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat Immunol. 2005;6(8):769-776.
    • (2005) Nat Immunol , vol.6 , Issue.8 , pp. 769-776
    • Napolitani, G.1    Rinaldi, A.2    Bertoni, F.3    Sallusto, F.4    Lanzavecchia, A.5
  • 72
    • 84856988610 scopus 로고    scopus 로고
    • Simultaneous targeting of toll-and nod-like receptors induces effective tumorspecific immune responses
    • Garaude J, Kent A, van Rooijen N, Blander JM. Simultaneous targeting of toll-and nod-like receptors induces effective tumorspecific immune responses. Sci Transl Med. 2012;4(120):120ra116.
    • (2012) Sci Transl Med , vol.4 , Issue.120 , pp. 120ra116
    • Garaude, J.1    Kent, A.2    Van Rooijen, N.3    Blander, J.M.4
  • 73
    • 84894593765 scopus 로고    scopus 로고
    • Toll-like receptor 7/8 (TLR7/8) and TLR9 agonists cooperate to enhance HIV-1 envelope antibody responses in rhesus macaques
    • Moody MA, et al. Toll-like receptor 7/8 (TLR7/8) and TLR9 agonists cooperate to enhance HIV-1 envelope antibody responses in rhesus macaques. J Virol. 2014;88(6):3329-3339.
    • (2014) J Virol , vol.88 , Issue.6 , pp. 3329-3339
    • Moody, M.A.1
  • 74
  • 77
    • 84896747213 scopus 로고    scopus 로고
    • A dual TLR agonist adjuvant enhances the immunogenicity and protective efficacy of the tuberculosis vaccine antigen ID93
    • Orr MT, et al. A dual TLR agonist adjuvant enhances the immunogenicity and protective efficacy of the tuberculosis vaccine antigen ID93. PLoS One. 2014;9(1):e83884.
    • (2014) PLoS One , vol.9 , Issue.1 , pp. e83884
    • Orr, M.T.1
  • 78
    • 79952107221 scopus 로고    scopus 로고
    • Contributions of humoral and cellular immunity to vaccine-induced protection in humans
    • Amanna IJ, Slifka MK. Contributions of humoral and cellular immunity to vaccine-induced protection in humans. Virology. 2011;411(2):206-215.
    • (2011) Virology , vol.411 , Issue.2 , pp. 206-215
    • Amanna, I.J.1    Slifka, M.K.2
  • 79
    • 84875538701 scopus 로고    scopus 로고
    • The actin and tetraspanin networks organize receptor nanoclusters to regulate B cell receptor-mediated signaling
    • Mattila PK, et al. The actin and tetraspanin networks organize receptor nanoclusters to regulate B cell receptor-mediated signaling. Immunity. 2013;38(3):461-474.
    • (2013) Immunity , vol.38 , Issue.3 , pp. 461-474
    • Mattila, P.K.1
  • 80
    • 0042689324 scopus 로고
    • Molecular determinants of immunogenicity: The immunon model of immune response
    • Dintzis H, Dintzis R, Vogelstein B. Molecular determinants of immunogenicity: the immunon model of immune response. Proc Natl Acad Sci U S A. 1976;73(10):3671-3675.
    • (1976) Proc Natl Acad Sci U S A , vol.73 , Issue.10 , pp. 3671-3675
    • Dintzis, H.1    Dintzis, R.2    Vogelstein, B.3
  • 82
    • 84901744022 scopus 로고    scopus 로고
    • Delivery of polysaccharides using polymer particles: Implications on size-dependent immunogenicity, opsonophagocytosis, and protective immunity
    • Anish C, Khan N, Upadhyay AK, Sehgal D, Panda AK. Delivery of polysaccharides using polymer particles: implications on size-dependent immunogenicity, opsonophagocytosis, and protective immunity. Mol Pharm. 2014;11(3):922-937.
    • (2014) Mol Pharm , vol.11 , Issue.3 , pp. 922-937
    • Anish, C.1    Khan, N.2    Upadhyay, A.K.3    Sehgal, D.4    Panda, A.K.5
  • 83
    • 33644777602 scopus 로고    scopus 로고
    • Monovalent ligation of the B cell receptor induces receptor activation but fails to promote antigen presentation
    • Kim Y-M, Pan JY-J, Korbel GA, Peperzak V, Boes M, Ploegh HL. Monovalent ligation of the B cell receptor induces receptor activation but fails to promote antigen presentation. Proc Natl Acad Sci U S A. 2006;103(9):3327-3332.
    • (2006) Proc Natl Acad Sci U S A , vol.103 , Issue.9 , pp. 3327-3332
    • Kim, Y.-M.1    Pan, J.Y.-J.2    Korbel, G.A.3    Peperzak, V.4    Boes, M.5    Ploegh, H.L.6
  • 84
    • 0036856574 scopus 로고    scopus 로고
    • Regulation of IgG antibody responses by epitope density and CD21-mediated costimulation
    • Jegerlehner A, Storni T, Lipowsky G, Schmid M, Pumpens P, Bachmann MF. Regulation of IgG antibody responses by epitope density and CD21-mediated costimulation. Eur J Immunol. 2002;32(11):3305-3314.
    • (2002) Eur J Immunol , vol.32 , Issue.11 , pp. 3305-3314
    • Jegerlehner, A.1    Storni, T.2    Lipowsky, G.3    Schmid, M.4    Pumpens, P.5    Bachmann, M.F.6
  • 85
    • 84900009827 scopus 로고    scopus 로고
    • Targeting and activation of antigenspecific B-cells by calcium phosphate nanoparticles loaded with protein antigen
    • Temchura VV, Kozlova D, Sokolova V, Uberla K, Epple M. Targeting and activation of antigenspecific B-cells by calcium phosphate nanoparticles loaded with protein antigen. Biomaterials. 2014;35(23):6098-6105.
    • (2014) Biomaterials , vol.35 , Issue.23 , pp. 6098-6105
    • Temchura, V.V.1    Kozlova, D.2    Sokolova, V.3    Uberla, K.4    Epple, M.5
  • 87
    • 44449151190 scopus 로고    scopus 로고
    • Viruslike display of a neo-self antigen reverses B cell anergy in a B cell receptor transgenic mouse model
    • Chackerian B, Durfee MR, Schiller JT. Viruslike display of a neo-self antigen reverses B cell anergy in a B cell receptor transgenic mouse model. J Immunol. 2008;180(9):5816-5825.
    • (2008) J Immunol , vol.180 , Issue.9 , pp. 5816-5825
    • Chackerian, B.1    Durfee, M.R.2    Schiller, J.T.3
  • 88
    • 84886185369 scopus 로고    scopus 로고
    • Virus-like particle vaccines: Advantages and challenges
    • In: Singh M, Srivastava IK, eds.. Hoboken, New Jersey, USA: John Wiley & Sons, Inc
    • Ross TM, et al. Virus-like particle vaccines: advantages and challenges. In: Singh M, Srivastava IK, eds. Development of Vaccines: From Discovery to Clinical Testing. Hoboken, New Jersey, USA: John Wiley & Sons, Inc; 2011:95-124.
    • (2011) Development of Vaccines: From Discovery to Clinical Testing , pp. 95-124
    • Ross, T.M.1
  • 90
    • 84881580700 scopus 로고    scopus 로고
    • A self-adjuvanting supramolecular vaccine carrying a folded protein antigen
    • Hudalla GA, et al. A self-adjuvanting supramolecular vaccine carrying a folded protein antigen. Adv Healthc Mater. 2013;2(8):1114-1119.
    • (2013) Adv Healthc Mater , vol.2 , Issue.8 , pp. 1114-1119
    • Hudalla, G.A.1
  • 91
    • 84863568613 scopus 로고    scopus 로고
    • Self-assembled peptide nanofibers raising durable antibody responses against a malaria epitope
    • Rudra JS, et al. Self-assembled peptide nanofibers raising durable antibody responses against a malaria epitope. Biomaterials. 2012;33(27):6476-6484.
    • (2012) Biomaterials , vol.33 , Issue.27 , pp. 6476-6484
    • Rudra, J.S.1
  • 92
    • 77955840812 scopus 로고    scopus 로고
    • Synthetic virus-like particles from self-assembling coiledcoil lipopeptides and their use in antigen display to the immune system
    • Boato F, Thomas RM, Ghasparian A, Freund-Renard A, Moehle K, Robinson JA. Synthetic virus-like particles from self-assembling coiledcoil lipopeptides and their use in antigen display to the immune system. Angew Chem Int Ed Engl. 2007;119(47):9173-9176.
    • (2007) Angew Chem Int Ed Engl , vol.119 , Issue.47 , pp. 9173-9176
    • Boato, F.1    Thomas, R.M.2    Ghasparian, A.3    Freund-Renard, A.4    Moehle, K.5    Robinson, J.A.6
  • 93
    • 84934954773 scopus 로고    scopus 로고
    • HIV-1 vaccines
    • Jardine JG, et al. HIV-1 vaccines. Science. 2015;349(6244):156-161.
    • (2015) Science , vol.349 , Issue.6244 , pp. 156-161
    • Jardine, J.G.1
  • 94
    • 84882413295 scopus 로고    scopus 로고
    • Multiple antigenpresenting system (MAPS) to induce comprehensive B-and T-cell immunity
    • Zhang F, Lu YJ, Malley R. Multiple antigenpresenting system (MAPS) to induce comprehensive B-and T-cell immunity. Proc Natl Acad Sci U S A. 2013;110(33):13564-13569.
    • (2013) Proc Natl Acad Sci U S A , vol.110 , Issue.33 , pp. 13564-13569
    • Zhang, F.1    Lu, Y.J.2    Malley, R.3
  • 95
    • 34447623566 scopus 로고    scopus 로고
    • B cells acquire particulate antigen in a macrophage-rich area at the boundary between the follicle and the subcapsular sinus of the lymph node
    • Carrasco YR, Batista FD. B cells acquire particulate antigen in a macrophage-rich area at the boundary between the follicle and the subcapsular sinus of the lymph node. Immunity. 2007;27(1):160-171.
    • (2007) Immunity , vol.27 , Issue.1 , pp. 160-171
    • Carrasco, Y.R.1    Batista, F.D.2
  • 96
    • 35948935059 scopus 로고    scopus 로고
    • Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells
    • Junt T, et al. Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature. 2007;450(7166):110-114.
    • (2007) Nature , vol.450 , Issue.7166 , pp. 110-114
    • Junt, T.1
  • 97
    • 34548044827 scopus 로고    scopus 로고
    • Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells
    • Phan TG, Grigorova I, Okada T, Cyster JG. Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells. Nat Immunol. 2007;8(9):992-1000.
    • (2007) Nat Immunol , vol.8 , Issue.9 , pp. 992-1000
    • Phan, T.G.1    Grigorova, I.2    Okada, T.3    Cyster, J.G.4
  • 98
    • 84905111574 scopus 로고    scopus 로고
    • Trans-nodal migration of resident dendritic cells into medullary interfollicular regions initiates immunity to influenza vaccine
    • Woodruff MC, et al. Trans-nodal migration of resident dendritic cells into medullary interfollicular regions initiates immunity to influenza vaccine. J Exp Med. 2014;211(8):1611-1621.
    • (2014) J Exp Med , vol.211 , Issue.8 , pp. 1611-1621
    • Woodruff, M.C.1
  • 99
    • 34247149876 scopus 로고    scopus 로고
    • The humoral immune response is initiated in lymph nodes by B cells that acquire soluble antigen directly in the follicles
    • Pape KA, Catron DM, Itano AA, Jenkins MK. The humoral immune response is initiated in lymph nodes by B cells that acquire soluble antigen directly in the follicles. Immunity. 2007;26(4):491-502.
    • (2007) Immunity , vol.26 , Issue.4 , pp. 491-502
    • Pape, K.A.1    Catron, D.M.2    Itano, A.A.3    Jenkins, M.K.4
  • 100
    • 60149086845 scopus 로고    scopus 로고
    • Conduits mediate transport of low-molecular-weight antigen to lymph node follicles
    • Roozendaal R, et al. Conduits mediate transport of low-molecular-weight antigen to lymph node follicles. Immunity. 2009;30(2):264-276.
    • (2009) Immunity , vol.30 , Issue.2 , pp. 264-276
    • Roozendaal, R.1
  • 101
    • 21144444056 scopus 로고    scopus 로고
    • Dynamics and function of langerhans cells in vivo: Dermal dendritic cells colonize lymph node areasdistinct from slower migrating langerhans cells
    • Kissenpfennig A, et al. Dynamics and function of langerhans cells in vivo: dermal dendritic cells colonize lymph node areasdistinct from slower migrating langerhans cells. Immunity. 2005;22(5):643-654.
    • (2005) Immunity , vol.22 , Issue.5 , pp. 643-654
    • Kissenpfennig, A.1
  • 102
    • 35349014587 scopus 로고    scopus 로고
    • Molecular signature of CD8+ T cell exhaustion during chronic viral infection
    • Wherry EJ, et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity. 2007;27(4):670-684.
    • (2007) Immunity , vol.27 , Issue.4 , pp. 670-684
    • Wherry, E.J.1
  • 103
    • 84866275978 scopus 로고    scopus 로고
    • Prolonged persistence of measles virus RNA is characteristic of primary infection dynamics
    • Lin WH, Kouyos RD, Adams RJ, Grenfell BT, Griffin DE. Prolonged persistence of measles virus RNA is characteristic of primary infection dynamics. Proc Natl Acad Sci U S A. 2012;109(37):14989-14994.
    • (2012) Proc Natl Acad Sci U S A , vol.109 , Issue.37 , pp. 14989-14994
    • Lin, W.H.1    Kouyos, R.D.2    Adams, R.J.3    Grenfell, B.T.4    Griffin, D.E.5
  • 104
    • 77953499055 scopus 로고    scopus 로고
    • Antigen persistence and the control of local T cell memory by migrant respiratory dendritic cells after acute virus infection
    • Kim TS, Hufford MM, Sun J, Fu YX, Braciale TJ. Antigen persistence and the control of local T cell memory by migrant respiratory dendritic cells after acute virus infection. J Exp Med. 2010;207(6):1161-1172.
    • (2010) J Exp Med , vol.207 , Issue.6 , pp. 1161-1172
    • Kim, T.S.1    Hufford, M.M.2    Sun, J.3    Fu, Y.X.4    Braciale, T.J.5
  • 105
    • 33846830004 scopus 로고    scopus 로고
    • Persistent antigen presentation after acute vesicular stomatitis virus infection
    • Turner DL, Cauley LS, Khanna KM, Lefrancois L. Persistent antigen presentation after acute vesicular stomatitis virus infection. J Virol. 2007;81(4):2039-2046.
    • (2007) J Virol , vol.81 , Issue.4 , pp. 2039-2046
    • Turner, D.L.1    Cauley, L.S.2    Khanna, K.M.3    Lefrancois, L.4
  • 106
    • 84875549975 scopus 로고    scopus 로고
    • Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype
    • Baumjohann D, et al. Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype. Immunity. 2013;38(3):596-605.
    • (2013) Immunity , vol.38 , Issue.3 , pp. 596-605
    • Baumjohann, D.1
  • 107
    • 84940995726 scopus 로고    scopus 로고
    • Antigen presentation kinetics control T cell/dendritic cell interactions and follicular helper T cell generation in vivo
    • Benson RA, MacLeod MK, Hale BG, Patakas A, Garside P, Brewer JM. Antigen presentation kinetics control T cell/dendritic cell interactions and follicular helper T cell generation in vivo. Elife. 2015;4:e06994.
    • (2015) Elife , vol.4 , pp. e06994
    • Benson, R.A.1    MacLeod, M.K.2    Hale, B.G.3    Patakas, A.4    Garside, P.5    Brewer, J.M.6
  • 108
    • 42449141017 scopus 로고    scopus 로고
    • Antigen kinetics determines immune reactivity
    • Johansen P, et al. Antigen kinetics determines immune reactivity. Proc Natl Acad Sci U S A. 2008;105(13):5189-5194.
    • (2008) Proc Natl Acad Sci U S A , vol.105 , Issue.13 , pp. 5189-5194
    • Johansen, P.1
  • 109
    • 34548027000 scopus 로고    scopus 로고
    • Inflammation directs memory precursor and short-lived effector CD8+ T cell fates via the graded expression of T-bet transcription factor
    • Joshi NS, et al. Inflammation directs memory precursor and short-lived effector CD8+ T cell fates via the graded expression of T-bet transcription factor. Immunity. 2007;27(2):281-295.
    • (2007) Immunity , vol.27 , Issue.2 , pp. 281-295
    • Joshi, N.S.1
  • 110
    • 0034210006 scopus 로고    scopus 로고
    • Localization dose and time of antigens determine immune reactivity
    • Zinkernagel RM. Localization dose and time of antigens determine immune reactivity. Semin Immunol. 2000;12(3):163-171.
    • (2000) Semin Immunol , vol.12 , Issue.3 , pp. 163-171
    • Zinkernagel, R.M.1
  • 111
    • 80052665758 scopus 로고    scopus 로고
    • Duration of antigen availability influences the expansion and memory differentiation of T cells
    • Blair DA, et al. Duration of antigen availability influences the expansion and memory differentiation of T cells. J Immunol. 2011;187(5):2310-2321.
    • (2011) J Immunol , vol.187 , Issue.5 , pp. 2310-2321
    • Blair, D.A.1
  • 112
    • 33645856486 scopus 로고    scopus 로고
    • Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation
    • Paus D, Phan TG, Chan TD, Gardam S, Basten A, Brink R. Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation. J Exp Med. 2006;203(4):1081-1091.
    • (2006) J Exp Med , vol.203 , Issue.4 , pp. 1081-1091
    • Paus, D.1    Phan, T.G.2    Chan, T.D.3    Gardam, S.4    Basten, A.5    Brink, R.6
  • 113
    • 84924067611 scopus 로고    scopus 로고
    • Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling
    • Quinn KM, et al. Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling. J Clin Invest. 2015;125(3):1129-1146.
    • (2015) J Clin Invest , vol.125 , Issue.3 , pp. 1129-1146
    • Quinn, K.M.1
  • 114
    • 40449088958 scopus 로고    scopus 로고
    • CD8 T cell expansion and memory differentiation are facilitated by simultaneous and sustained exposure to antigenic and inflammatory milieu
    • Shaulov A, Murali-Krishna K. CD8 T cell expansion and memory differentiation are facilitated by simultaneous and sustained exposure to antigenic and inflammatory milieu. J Immunol. 2008;180(2):1131-1138.
    • (2008) J Immunol , vol.180 , Issue.2 , pp. 1131-1138
    • Shaulov, A.1    Murali-Krishna, K.2
  • 115
    • 0030460025 scopus 로고    scopus 로고
    • In vivo distribution of radioactivity in mice after injection of biodegradable polymer microspheres containing 14C-labeled tetanus toxoid
    • Gupta RK, Chang AC, Griffin P, Rivera R, Siber GR. In vivo distribution of radioactivity in mice after injection of biodegradable polymer microspheres containing 14C-labeled tetanus toxoid. Vaccine. 1996;14(15):1412-1416.
    • (1996) Vaccine , vol.14 , Issue.15 , pp. 1412-1416
    • Gupta, R.K.1    Chang, A.C.2    Griffin, P.3    Rivera, R.4    Siber, G.R.5
  • 116
    • 84862652390 scopus 로고    scopus 로고
    • Alum adjuvant: Some of the tricks of the oldest adjuvant
    • Kool M, Fierens K, Lambrecht BN. Alum adjuvant: some of the tricks of the oldest adjuvant. J Med Microbiol. 2012;61(pt 7):927-934.
    • (2012) J Med Microbiol , vol.61 , pp. 927-934
    • Kool, M.1    Fierens, K.2    Lambrecht, B.N.3
  • 118
    • 77950596439 scopus 로고    scopus 로고
    • Mechanism of immunopotentiation by aluminum-containing adjuvants elucidated by the relationship between antigen retention at the inoculation site and the immune response
    • Noe SM, Green MA, HogenEsch H, Hem SL. Mechanism of immunopotentiation by aluminum-containing adjuvants elucidated by the relationship between antigen retention at the inoculation site and the immune response. Vaccine. 2010;28(20):3588-3594.
    • (2010) Vaccine , vol.28 , Issue.20 , pp. 3588-3594
    • Noe, S.M.1    Green, M.A.2    HogenEsch, H.3    Hem, S.L.4
  • 119
    • 0018746463 scopus 로고
    • A single-step immunization by sustained antigen release
    • Preis I, Langer RS. A single-step immunization by sustained antigen release. J Immunol Methods. 1979;28(1-2):193-197.
    • (1979) J Immunol Methods , vol.28 , Issue.1-2 , pp. 193-197
    • Preis, I.1    Langer, R.S.2
  • 120
    • 35349027729 scopus 로고    scopus 로고
    • Nanoparticles and microparticles as vaccine-delivery systems
    • Singh M, Chakrapani A, O'Hagan D. Nanoparticles and microparticles as vaccine-delivery systems. Expert Rev Vaccines. 2007;6(5):797-808.
    • (2007) Expert Rev Vaccines , vol.6 , Issue.5 , pp. 797-808
    • Singh, M.1    Chakrapani, A.2    O'Hagan, D.3
  • 121
    • 81355141475 scopus 로고    scopus 로고
    • The long-term potential of biodegradable poly(lactideco-glycolide) microparticles as the nextgeneration vaccine adjuvant
    • Jain S, O'Hagan DT, Singh M. The long-term potential of biodegradable poly(lactideco-glycolide) microparticles as the nextgeneration vaccine adjuvant. Expert Rev Vaccines. 2011;10(12):1731-1742.
    • (2011) Expert Rev Vaccines , vol.10 , Issue.12 , pp. 1731-1742
    • Jain, S.1    O'Hagan, D.T.2    Singh, M.3
  • 122
    • 84868206060 scopus 로고    scopus 로고
    • Microneedles for drug and vaccine delivery
    • Kim YC, Park JH, Prausnitz MR. Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev. 2012;64(14):1547-1568.
    • (2012) Adv Drug Deliv Rev , vol.64 , Issue.14 , pp. 1547-1568
    • Kim, Y.C.1    Park, J.H.2    Prausnitz, M.R.3
  • 123
    • 84883867736 scopus 로고    scopus 로고
    • Development and clinical study of a self-dissolving microneedle patch for transcutaneous immunization device
    • Hirobe S, et al. Development and clinical study of a self-dissolving microneedle patch for transcutaneous immunization device. Pharm Res. 2013;30(10):2664-2674.
    • (2013) Pharm Res , vol.30 , Issue.10 , pp. 2664-2674
    • Hirobe, S.1
  • 124
    • 77955417028 scopus 로고    scopus 로고
    • Dissolving polymer microneedle patches for influenza vaccination
    • Sullivan SP, et al. Dissolving polymer microneedle patches for influenza vaccination. Nat Med. 2010;16(8):915-920.
    • (2010) Nat Med , vol.16 , Issue.8 , pp. 915-920
    • Sullivan, S.P.1
  • 126
    • 84872082784 scopus 로고    scopus 로고
    • Composite dissolving microneedles for coordinated control of antigen and adjuvant delivery kinetics in transcutaneous vaccination
    • Demuth PC, Garcia-Beltran WF, Ai-Ling ML, Hammond PT, Irvine DJ. Composite dissolving microneedles for coordinated control of antigen and adjuvant delivery kinetics in transcutaneous vaccination. Adv Funct Mater. 2013;23(2):161-172.
    • (2013) Adv Funct Mater , vol.23 , Issue.2 , pp. 161-172
    • Demuth, P.C.1    Garcia-Beltran, W.F.2    Ai-Ling, M.L.3    Hammond, P.T.4    Irvine, D.J.5
  • 127
    • 84925378659 scopus 로고    scopus 로고
    • Dissolving microneedle delivery of nanoparticle-encapsulated antigen elicits efficient cross-priming and Th1 immune responses by murine Langerhans cells
    • Zaric M, et al. Dissolving microneedle delivery of nanoparticle-encapsulated antigen elicits efficient cross-priming and Th1 immune responses by murine Langerhans cells. J Invest Dermatol. 2015;135(2):425-434.
    • (2015) J Invest Dermatol , vol.135 , Issue.2 , pp. 425-434
    • Zaric, M.1
  • 128
    • 84891782974 scopus 로고    scopus 로고
    • Implantable silk composite microneedles for programmable vaccine release kinetics and enhanced immunogenicity in transcutaneous immunization
    • DeMuth PC, Min Y, Irvine DJ, Hammond PT. Implantable silk composite microneedles for programmable vaccine release kinetics and enhanced immunogenicity in transcutaneous immunization. Adv Healthc Mater. 2014;3(1):47-58.
    • (2014) Adv Healthc Mater , vol.3 , Issue.1 , pp. 47-58
    • DeMuth, P.C.1    Min, Y.2    Irvine, D.J.3    Hammond, P.T.4
  • 129
    • 84875412118 scopus 로고    scopus 로고
    • Polymer multilayer tattooing for enhanced DNA vaccination
    • DeMuth PC, et al. Polymer multilayer tattooing for enhanced DNA vaccination. Nat Mater. 2013;12(4):367-376.
    • (2013) Nat Mater , vol.12 , Issue.4 , pp. 367-376
    • DeMuth, P.C.1
  • 130
    • 84864364745 scopus 로고    scopus 로고
    • Stabilization of vaccines and antibiotics in silk and eliminating the cold chain
    • Zhang J, et al. Stabilization of vaccines and antibiotics in silk and eliminating the cold chain. Proc Natl Acad Sci U S A. 2012;109(30):11981-11986.
    • (2012) Proc Natl Acad Sci U S A , vol.109 , Issue.30 , pp. 11981-11986
    • Zhang, J.1
  • 131
    • 58949100114 scopus 로고    scopus 로고
    • Infection-mimicking materials to program dendritic cells in situ
    • Ali OA, Huebsch N, Cao L, Dranoff G, Mooney DJ. Infection-mimicking materials to program dendritic cells in situ. Nat Mater. 2009;8(2):151-158.
    • (2009) Nat Mater , vol.8 , Issue.2 , pp. 151-158
    • Ali, O.A.1    Huebsch, N.2    Cao, L.3    Dranoff, G.4    Mooney, D.J.5
  • 132
    • 84896523011 scopus 로고    scopus 로고
    • Identification of immune factors regulating antitumor immunity using polymeric vaccines with multiple adjuvants
    • Ali OA, et al. Identification of immune factors regulating antitumor immunity using polymeric vaccines with multiple adjuvants. Cancer Res. 2014;74(6):1670-1681.
    • (2014) Cancer Res , vol.74 , Issue.6 , pp. 1670-1681
    • Ali, O.A.1
  • 133
    • 77953720628 scopus 로고    scopus 로고
    • In situ regulation of DC subsets and T cells mediates tumor regression in mice
    • Ali OA, Emerich D, Dranoff G, Mooney DJ. In situ regulation of DC subsets and T cells mediates tumor regression in mice. Sci Transl Med. 2009;1(8):8ra19.
    • (2009) Sci Transl Med , vol.1 , Issue.8 , pp. 8ra19
    • Ali, O.A.1    Emerich, D.2    Dranoff, G.3    Mooney, D.J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.